Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC1 | Q13547 | 2/20 | 0.37 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.37 |
| ▸ | MAPT | P10636 | 3/20 | 0.36 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.36 |
| ▸ | XBP1 | P17861 | 1/20 | 0.36 |
| ▸ | PTGS1 | P23219 | 9/20 | 0.36 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.34 |
| ▸ | KCNJ11 | Q14654 | 2/20 | 0.33 |
| ▸ | MEN1 | O00255 | 2/20 | 0.33 |
| ▸ | NPC1 | O15118 | 2/20 | 0.33 |
| ▸ | RAB9A | P51151 | 2/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.33 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3777934 | 0.87 | KCNQ3 (0.33) | HDAC1MAPTNPSR1XBP1PTGS1 | |
| SCHEMBL12649015 | 0.86 | MAPT (0.43) | HDAC1HDAC6MAPTNPSR1XBP1 | |
| SCHEMBL24588326 | 0.84 | HDAC1 (0.40) | HDAC1HDAC6MAPTNPSR1XBP1 | |
| SCHEMBL9895426 | 0.82 | HDAC3 (0.44) | HDAC1HDAC6MAPTNPSR1XBP1 | |
| SCHEMBL3210164 | 0.81 | HDAC1 (0.34) | HDAC1MAPTNPSR1MEN1NPC1 | |
| SCHEMBL298806 | 0.81 | CYP1A2 (0.50) | MAPTKMT2A | |
| SCHEMBL3695537 | 0.80 | KCNQ3 (0.35) | MAPTKCNJ11MEN1KMT2ALMNA | |
| SCHEMBL3219952 | 0.80 | KCNQ3 (0.35) | HDAC1HDAC6MAPTNPSR1XBP1 | |
| SCHEMBL11987619 | 0.80 | PKM (0.43) | HDAC1HDAC6MAPTPTGS1HDAC2 | |
| SCHEMBL3213487 | 0.79 | KDM4E (0.34) | HDAC1KCNJ11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120122975-A1 | 4-CYANO-3-BENZOYLAMINO-N-PHENYL-BENZAMIDES FOR USE IN PEST CONTROL | SYNGENTA CROP PROTECTION LLC (US) | 2012-05-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120122975-A1 | 4-CYANO-3-BENZOYLAMINO-N-PHENYL-BENZAMIDES FOR USE IN PEST CONTROL | NISCH, AADAC, ACHE | HDAC1 220/4885HDAC6 20/4885MAPT 3060/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.